Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-09-05-Speech-2-113"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-09-05"^^xsd:date2
dcterms:Is Part Of	lp_eu:Aids2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20000905.9.2-113"2
lpv:hasSubsequent	lp_eu:2000-09-05-Speech-2-1142
lpv:speaker	lp:Marie-Arlette Carlotti2
lpv:spokenAs	vice-chair; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (1999-09-14--2002-01-14)3 substitute; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (1999-07-22--2002-01-14)3 unknown; Parti socialiste (1999-07-20--2004-07-19)3 member; Committee on Development and Cooperation (1999-07-21--2002-01-14)3 member; PES (1999-07-20--2004-07-19)3
lpv:translated text	"Madam President, in my view an important step was taken at the Durban International Aids Conference: although prevention also remains essential for combating this plague, the issue of access to treatment was finally placed at the heart of the debate. Durban made it possible to approach the essential issues – the price of medication and the development of generic medication – frankly, and move forward in our thinking about intellectual property rights and compulsory licences. It was about time. The conduct of the big drug companies has too often contributed to imposing a two-speed treatment system: medication for the rich and despair for the poor. That is why the initiative from the pharmaceutical laboratories on the price of medication, launched on the fringe of the conference, constitutes an encouraging beginning, as long as it was not just announced for effect. The G8 Summit at Okinawa has also made it possible to set the seal on the commitment of the rich countries and set targets to lessen the ravages of Aids in Africa over the next ten years, but, unfortunately, the issue of resources was not really dealt with. This very day a meeting should be taking place in New York, under the auspices of UNDP, between public and private operators to sign up to and finance the Aids action plan for South Africa. There really is a feeling that people are finally beginning to ask the right questions. Now perhaps the right answers should be provided. Obviously the European Union is not standing on the sidelines of this mobilisation but I think we should step up a gear, and I heard the French Presidency express that hope. We eagerly await the Commission’s communication, with guidelines and proposals for combating the major transmissible diseases: Aids of course, but also malaria and tuberculosis. Aware that the time has come not just for reflection but for action too, we expect really concrete proposals permitting very rapid progress. I am thinking, in particular, of the debates on industrial property rights and compulsory licences. I am thinking of the development of the International Therapeutic Solidarity Fund launched to raise international funds to give poor countries access to the new therapies, which must expand. I am thinking of the organisation of an international conference involving poor countries, the pharmaceutical industries, the NGOs and the donors. Perhaps the round table of 28 September, organised by the Commission, in liaison with WHO and UNAIDS could be the first stage in setting that up?"@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph